FLT3 inhibitors for relapsed or refractory acute myeloid leukaemia Journal Article
| Author: | Stein, E. M. |
| Article Title: | FLT3 inhibitors for relapsed or refractory acute myeloid leukaemia |
| Keywords: | event free survival; treatment response; unclassified drug; overall survival; note; neutrophil count; gene frequency; protein tyrosine kinase inhibitor; allogeneic hematopoietic stem cell transplantation; leukemia relapse; erythrocyte transfusion; thrombocyte transfusion; platelet count; leukemia remission; phase 2 clinical trial (topic); phase 3 clinical trial (topic); cd135 antigen; phase 1 clinical trial (topic); midostaurin; acute myeloid leukemia; consolidation chemotherapy; quizartinib; human; priority journal; crenolanib; gilteritinib; ff 10101 |
| Journal Title: | Lancet Oncology |
| Volume: | 19 |
| Issue: | 7 |
| ISSN: | 1470-2045 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2018-07-01 |
| Start Page: | 849 |
| End Page: | 850 |
| Language: | English |
| DOI: | 10.1016/s1470-2045(18)30335-8 |
| PROVIDER: | scopus |
| PUBMED: | 29859852 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 1 August 2018 -- Source: Scopus |
